A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
The 50 companies with the biggest pandemic-era gains have collectively lost $1.5 trillion in market value since the close of 2020.
A special $7.5 million debt threshold for filing is due to expire in June, when it will revert to the previous $2.7 million limit.
Some of the more reliable office building tenants are reversing course by letting leases expire or subleasing space across major cities.
The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.
The company’s stock ran higher after the company buoyed investors’ hopes that its technology will boost a lineup of new popular drugs.
Fewer people are working than almost any other time in U.S. history.
Pfizer’s stock slumped its lowest level in more than 10 years. The world’s moved on from the pandemic, and nobody loves you when you’re down.
Roche agreed Monday to acquire anti-obesity drug developer Carmot Therapeutics for an appetizing $3.1 billion.
A white-hot healthcare sector powered an much of the job growth in the past six months, according to a Wall Street Journal analysis.
Amazon said Wednesday it plans to offer Prime subscribers low-cost annual memberships to its boutique One Medical primary care business.
Moderna posted a quarterly loss of $3.63 billion, half of which was accounted for by unused Covid-19 shots past their expiration date.
China is aggressively pushing a revisionist history of the pandemic, even as it continues to clash with U.S. officials about its origins.